2003
Impact
|
1. |
Ebner, K., A. Bandion, B. R. Binder, R. De Martin, and J. A. Schmid. 2003. GMCSF activates NF-{kappa}B via direct interaction of the GMCSF-receptor with I{kappa}B kinase {beta}. Blood, Vol. 102, p192-199 |
9.273 |
|
2. |
Gruber, F., P. Hufnagl, R. Hofer-Warbinek, J. A. Schmid, J. M. Breuss, R. Huber-Beckmann, M. Lucerna, N. Papac, H. Harant, I. Lindley, R. de Martin, and B. R. Binder. 2003. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNFalpha -induced PAI-1 expression. Blood, Vol. 101, p3042-3048 |
9.273 |
|
3. |
Lucerna, M., D. Mechtcheriakova, A. Kadl, G. Schabbauer, R. Schafer, F. Gruber, Y. Koshelnick, H. D. Muller, K. Issbrucker, M. Clauss, B. R. Binder, and E. Hofer. 2003. NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. J. of Biol. Chem. Vol. 278, p11433-11440 |
6.696 |
|
4. |
Rezaie-Majd, A., G. W. Prager, R. A. Bucek, G. H. Schernthaner, T. Maca, H. G. Kress, P. Valent, B. R. Binder, E. Minar, and M. Baghestanian. 2003. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. Vol. 23, p397-403 |
5.816 |
|
5. |
Uchiba, M., K. Okajima, C. Kaun, B. R. Binder, and J. Wojta. 2003. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro. Crit. Care Med. Vol. 31, p1147-1153 |
3.486 |
|
6. |
Huber J, Bochkov VN, Binder BR, Leitinger N. The Isoprostane 8-iso-PGE(2) Stimulates Endothelial Cells to Bind Monocytes via Cyclic AMP- and p38 MAP Kinase-Dependent Signaling Pathways. Antioxid Redox Signal 2003 Apr;5(2), p163-169 |
0 |
|
7. |
Niessner A, Kaun C, Zorn G, Speidl W, Turel Z, Christiansen G, Pedersen AS, Birkelund S, Simon S, Georgopoulos A, Graninger W, de Martin R, Lipp J, Binder BR, Maurer G, Huber K, Wojta J.Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway. J Infect Dis. 2003 Jul 1, Vol. 188(1), p108-13. Epub 2003 Jun 12 |
4.910 |
|
8. |
Krebs M, Geiger M, Polak K, Vales A, Schmetterer L, Wagner OF, Waldhausl W, Binder BR, Roden M.Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man. Thromb Haemost. 2003 Sep, Vol. 90(3), p422-8 |
4.910 |
|
9. |
Leitinger N. Cholesteryl ester oxidation products in atherosclerosis. Mol Aspects Med. 2003 Oct;24(4-5):239-50. |
0 |
|
10. |
Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR. Vascular endothelial growth factor (VEGF) induces rapid pro-urokinase (pro-uPA) activation on the surface of endothelial cells. Blood. 2003 Oct 2 [Epub ahead of print |
9.273 |
|
11. |
Daubenberger CA, Diaz D, Curcic M, Mueller MS, Spielmann T, Certa U, Lipp J, Pluschke G. Identification and characterization of a conserved, stage-specific gene product of Plasmodium falciparum recognized by parasite growth inhibitory antibodies. Infect Immun. 2003 Apr, Vol. 71(4), p2173-81 |
4.212 |
|
12. |
Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element binding protein (CREB). J Biol Chem. 2003 Sep 30 [Epub ahead of print]. |
6.696 |
|
13. |
Bochkov VN, Leitinger N. Anti-inflammatory properties of lipid oxidation products. J Mol Med. 2003 Sep 6 [Epub ahead of print]. |
3.498 |
|
14. |
Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol. 2003 Oct;14(5):421-30. |
7.028 |
|
15. |
Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res. 2003, Vol. 92(4), p371-377 |
9.213 |
|
16. |
Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR Vascular endothelial growth factor (VEGF) induces rapid pro-urokinase (pro-uPA) activation on the surface of endothelial cells. Blood. 2003 Oct 2 [Epub ahead of print]. |
9.273 |
|
17. |
Kopp CW, Hoelzenbein T, Steiner S, Marculescu R, Bergmeister H, Seidinger D, Mosberger I, Kaun C, Cejna M, Horvat R, Wojta J, Maurer G, Binder BR, Breuss JM, Ecker RC, De Martin R, Minar E. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. Blood. 2003 Oct 30 [Epub ahead of print]. |
9.273 |
|
18. |
Zhang WJ, Hufnagl P, Binder BR, Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost. 2003, Vol. 90(5), p904-914
|
4.910 |
|
19. |
MacKenzie CJ, Paul A, Wilson S, de Martin R, Baker AH, Plevin R. Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling. Br J Pharmacol. 2003 Jul, Vol. 139(5), p1041-1049 |
3.502 |
|
20. |
Andreakos E, Smith C, Kiriakidis S, Monaco C, de Martin R, Brennan FM, Paleolog E, Feldmann M, Foxwell BM. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy. Arthritis Rheum. 2003 48(7), p1901-12.
|
7.389 |
|
21. |
Spahn L, Siligan C, Bachmaier R, Schmid JA, Aryee DN, Kovar H. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein. Oncogene. 2003 Oct 9, Vol. 22(44), p6819-629 |
6.737 |
|
22. |
Schmid JA. Cover the eyes of Lady Justice. EMBO Rep. 2003 Aug. 4(8), p734-736 |
12.459 |
|
23. |
Henkler F, Baumann B, Fotin-Mleczek M, Weingartner M, Schwenzer R, Peters N, Graness A, Wirth T, Scheurich P, Schmid JA, Wajant H. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. J Biol Chem. 2003 Aug 1, Vol. 278(31), p29216-29230 |
0 |
|
24. |
Schmid JA, Sitte HH. Fluorescence resonance energy transfer in the study of cancer pathways. Curr Opin Oncol. 2003 Jan,15(1):55-64 |
0 |
|
25. |
de Martin, R. (2003). NF-kB in the vasculature. in: Nuclear factor-kB: Regulation and role in disease. R. Beyaert (Ed.), Kluwer Acad. Publishers, 377-353. |
0 |
|
|
Gesamtimpact |
142.601 |
|
|
Durchschnitt |
5.704 |